Aberdeen Group
TWST icon

Aberdeen Group’s Twist Bioscience TWST Stock Holding History

Aberdeen Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-73,619
Closed -$3.5M – 973
2026
Q1 		$3.5M Sell
73,619
-234,497
-76% -$10.5M 0.01% 725
2025
Q4 		$9.77M Sell
308,116
-12,167
-4% -$380K 0.02% 615
2025
Q3 		$9.01M Buy
320,283
+158,879
+98% +$4.81M 0.01% 621
2025
Q2 		$5.94M Buy
+161,404
New +$5.58M 0.01% 682

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Aberdeen Group's TWST Position: Q2 2026 in Review

Aberdeen Group sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 73,619 shares — an estimated $3.5M sold.

Aberdeen Group first reported a position in TWST in Q2 2025 and held it in 4 quarters. The position peaked at $9.77M in Q4 2025. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Aberdeen Group reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
  • Aberdeen Group sold 73,619 Twist Bioscience shares in Q2 2026, an estimated $3.5M.
  • Aberdeen Group first reported a position in Twist Bioscience in Q2 2025 and held it in 4 quarters.
  • Aberdeen Group's Twist Bioscience position peaked at $9.77M in Q4 2025.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.